Human behaviour abetted deadly bacteria to become epidemic:

by IANS |

Human behaviour abetted deadly bacteria to become epidemic: Study New Delhi, July 5 (IANS) Scientists have, in a new study released on Friday, shown how Pseudomonas aeruginosa -- an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions -- have evolved rapidly and then spread globally over the last 200 years. Changes in human behaviour helped the bacteria -- responsible for over 5,00,000 deaths per year worldwide, of which over 3,00,000 are associated with antimicrobial resistance (AMR) -- to become epidemic, said the team from the University of Cambridge in the UK. People with conditions such as chronic obstructive pulmonary disease (COPD) -- smoking-related lung damage -- cystic fibrosis (CF), and non-CF bronchiectasis, are particularly susceptible to the bacteria. P. aeruginosa was found to exploit immune defects to persist in cystic fibrosis patients. To probe how P. aeruginosa evolved from an environmental organism into a specialised human pathogen the scientists examined DNA data from almost 10,000 samples taken from infected individuals, animals, and environments around the world. Using the data, the team created phylogenetic trees -- ‘family trees’ -- that show how the bacteria from the samples are related to each other. Their results, published in the journal Science, showed that almost seven in 10 infections are caused by just 21 genetic clones, or ‘branches’ of the family tree. These have rapidly evolved (by acquiring new genes from neighbouring bacteria) and then spread globally over the last 200 years. The bacteria spread occurred mostly as people began to live in densely populated areas, where air pollution made our lungs more susceptible to infection and where there were more opportunities for infections to spread. Besides spreading between CF patients, it can also spread with “worrying ease between other patients, too”, the team said. The study on P. aeruginosa “has taught us new things about the biology of cystic fibrosis and revealed important ways we might be able to improve immunity against invading bacteria in this and potentially other conditions,” said Professor Andres Floto, Director of the UK Cystic Fibrosis Innovation Hub at the University of Cambridge. --IANS rvt/dpb

Latest News
FM Nirmala Sitharaman set to present her 7th Budget, major reforms expected Tue, Jul 23, 2024, 10:01 AM
Over four lakh devotees perform ongoing Amarnath Yatra in 24 days Tue, Jul 23, 2024, 09:54 AM
Tech firm Kakao's founder arrested over alleged stock manipulation Tue, Jul 23, 2024, 09:46 AM
Tour de France winner Pogacar pulls out of Paris Olympics Tue, Jul 23, 2024, 09:28 AM
What BHU students expect from Budget 2024: Funding for research, hostel, job opportunities Mon, Jul 22, 2024, 05:01 PM
Mizoram's Aizawl to become 4th state capital in NE to have rail link by next year Mon, Jul 22, 2024, 04:55 PM
Don't share video circulated by terrorists: J&K Police warns public Mon, Jul 22, 2024, 04:52 PM
Major allocations likely for six guarantees in Telangana's full budget Mon, Jul 22, 2024, 04:50 PM
Root is so special that he could eventually overtake Sachin: Vaughan Mon, Jul 22, 2024, 04:48 PM
HM Amit Shah's verbal assault on Pawar-Thackeray evoke strong reactions from MVA, NCP Mon, Jul 22, 2024, 04:46 PM
Odisha Assembly session: Oppn stages walkout during Governor's address Mon, Jul 22, 2024, 04:44 PM
14 Palestinians killed in Israeli attacks in Khan Younis: Health authorities Mon, Jul 22, 2024, 04:43 PM
No special status to Bihar, reiterates Centre in Lok Sabha; RJD takes 'toy' jibe Mon, Jul 22, 2024, 04:37 PM
AI, machine learning job roles see 433 pc rise since 2022: Study Mon, Jul 22, 2024, 04:34 PM
Typhoon Prapiroon brings rainstorms, strong gusts to China Mon, Jul 22, 2024, 04:33 PM